Fig. 3From: Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative studyKaplan-Meier survival curves. a. Survival data of all patients with HCC after TACE with lipiodol only (n = 51). Median survival time was 25 months. b. Survival data of patients with HCC after TACE with lipiodol and DSM (n = 48). Median survival time was 28 monthsBack to article page